Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract


Authors: Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; Matasar, M. J.; Mccall, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; Portlock, C. S.; Straus, D. J.; Verwys, S.; Zelenetz, A. D.; Zhang, Z. G.; Younes, A.; Moskowitz, C. H.
Abstract Title: Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243501070
PROVIDER: wos
Notes: Meeting Abstract: 3085 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    272 Zhang
  2. Joachim Yahalom
    455 Yahalom
  3. Carol Portlock
    198 Portlock
  4. Craig Moskowitz
    388 Moskowitz
  5. Ariela Noy
    225 Noy
  6. Maria Lia Palomba
    163 Palomba
  7. Steven M Horwitz
    408 Horwitz
  8. Heiko Schoder
    330 Schoder
  9. Andrew D Zelenetz
    599 Zelenetz
  10. Alison Moskowitz
    179 Moskowitz
  11. Paul Hamlin
    186 Hamlin
  12. Matthew J Matasar
    149 Matasar
  13. Philip C Caron
    41 Caron
  14. David J Straus
    245 Straus
  15. Susan J McCall
    14 McCall
  16. Anita Kumar
    67 Kumar
  17. Alexandra G Jacob
    7 Jacob
  18. Anas Younes
    246 Younes
  19. Stephanie Lisl Verwys
    4 Verwys
Related MSK Work